Aristides Capital LLC Cassava Sciences Inc Transaction History

Aristides Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $200,502 - $423,895	16,235 New	16,235 $200,000
Q4 2023 Feb 13, 2024	BUY	$12.64 - $30.11 $126,400 - $301,100	10,000 New	10,000 $225,000
Q3 2022 Nov 15, 2022	BUY	$16.33 - $51.06 $101,180 - $316,367	6,196 New	6,196 $259,000
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $599,256 - $1.34 Million	-34,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $163,000 - $265,250	5,000 Added 16.78%	34,800 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $1.1 Million - $2.71 Million	29,800 New	29,800 $1.3 Million

196

13.8M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Aristides Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Aristides Capital LLC with notifications on news.